By Pete Brush ( August 24, 2011, 11:33 AM EDT) -- Par Pharmaceutical Cos. Inc. announced Wednesday it would pay $410 million in cash for generic-drug maker Anchen Pharmaceuticals Inc., a privately held outfit that has aggressively challenged patents for brand-name drugs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.